{"id":"nealbarbital","rwe":[],"tags":[{"label":"nealbarbital","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"censedal","offLabel":[],"synonyms":["nealbarbital","allylneopentylbarbituric acid","censedal","nealbarbitone","neallymal","nepental"],"timeline":[],"approvals":[],"brandName":"Censedal","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"nealbarbital","explanation":"Imagine your brain as a busy city with many different neighborhoods. Censedal is like a traffic controller that tries to calm down the traffic, but we don't know exactly how it does this or which neighborhoods it affects. This is a simplified explanation of how Censedal might work, but more research is needed to understand its effects on the brain.","oneSentence":"Censedal is thought to work by modulating neural activity, but its exact mechanism of action is unclear.","technicalDetail":"Censedal is a nealbarbital, a class of small molecule compounds that may interact with GABA receptors or other ion channels to modulate neural activity."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3792","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=NEALBARBITAL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:55:05.613011","biosimilars":[],"competitors":[],"genericName":"nealbarbital","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"25ATP958PA","CHEBI":"CHEBI:134970","INN_ID":"1013","UMLSCUI":"C0603636","ChEMBL_ID":"CHEMBL2106810","PUBCHEM_CID":"521716","MESH_SUPPLEMENTAL_RECORD_UI":"C008589"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Censedal (NEALBARBITAL) is a small molecule drug in the nealbarbital class, but information on its development, ownership, and commercial status is limited. Its target and mechanism of action are unknown. Censedal is not FDA-approved for any indications. The drug's pharmacokinetic properties, such as half-life and bioavailability, are also unknown. Further research is needed to understand Censedal's clinical utility and safety profile.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}